Terapia génica
La terapia génica administra una copia funcional de un gen, o corrige uno defectuoso, generalmente una sola vez y para toda la vida. Fabricar el vector que la administra suele ser más difícil que diseñar la terapia.
131 acciones
| # | Nombre | Posición | Valor operado |
Acciones del tema |
% del portafolio | Estado | |
|---|---|---|---|---|---|---|---|
| 301 |
Rafferty Asset Management
New York
| USD 37.2 M | -USD 17.8 M | 24 | 0.08% | Reducidas |
|
| 302 |
Mirae Asset Global Investments
Seoul,
South Korea
| USD 36.9 M | +USD 7.88 M | 34 | 0.05% | Aumentadas |
|
| 303 |
First Financial Bankshares
Abilene,
Texas
| USD 36.7 M | +USD 519 k | 1 | 0.69% | Aumentadas |
|
| 304 |
PC
Promethos Capital
Boston,
Massachusetts
| USD 36.6 M | +USD 4.53 M | 1 | 9.94% | Aumentadas |
|
| 305 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
| USD 36.4 M | +USD 2.67 M | 23 | 0.06% | Aumentadas |
|
| 306 |
Portolan Capital Management
Boston,
Massachusetts
| USD 36 M | +USD 4.5 M | 1 | 1.35% | Aumentadas |
|
| 307 |
TriCert Investment Counsel
Waterloo,
| USD 35.5 M | +USD 33.9 M | 1 | 3.3% | Nuevas |
|
| 308 |
Defilade Capital Management
Emeryville,
California
| USD 35.4 M | +USD 4.15 M | 1 | 4.74% | Aumentadas |
|
| 309 |
Hennion & Walsh Asset Management
Parsippany,
New Jersey
| USD 34.9 M | +USD 8.73 M | 14 | 1% | Aumentadas |
|
| 310 |
IQ EQ Fund Management
Dublin 2,
Ireland
| USD 34.8 M | -USD 177 k | 3 | 2.22% | Reducidas |
|
| 311 |
California Public Employees Retirement System
Sacramento,
California
| USD 34.8 M | -USD 9.1 M | 3 | 0.02% | Reducidas |
|
| 312 |
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
| USD 34.7 M | -USD 8.97 M | 2 | 0.26% | Reducidas |
|
| 313 |
Royce & Associates
New York
| USD 34.7 M | -USD 6.09 M | 3 | 0.28% | Reducidas |
|
| 314 |
Tidal Investments
Milwaukee,
Wisconsin
| USD 34.5 M | -USD 14.4 M | 11 | 0.06% | Reducidas |
|
| 315 |
DCP
Davern Capital Partners
Ny,
New York
| USD 34.4 M | -USD 3.32 M | 1 | 5.87% | Reducidas |
|
| 316 |
Burkehill Global Management
New York
| USD 34.3 M | +USD 14.5 M | 13 | 1.24% | Aumentadas |
|
| 317 |
PFM Health Sciences
San Francisco,
California
| USD 34.1 M | +USD 5.89 M | 6 | 2.92% | Aumentadas |
|
| 318 |
CIP
Champlain Investment Partners
Burlington,
Vermont
| USD 33.6 M | -USD 2.14 M | 1 | 0.86% | Reducidas |
|
| 319 |
BL
Bleichroeder LP
New York
| USD 33.3 M | +USD 2.11 M | 4 | 5.95% | Aumentadas |
|
| 320 |
Contrarius Group Holdings
Hamilton,
Bermuda
| USD 33.1 M | +USD 607 k | 1 | 1.52% | Aumentadas |
|
| 321 |
Pathstone Holdings
Englewood,
New Jersey
| USD 32.4 M | +USD 4.25 M | 8 | 0.09% | Aumentadas |
|
| 322 |
GPP
Great Point Partners
Greenwich,
Connecticut
| USD 32.3 M | +USD 12.2 M | 3 | 6.11% | Aumentadas |
|
| 323 |
Wealth Enhancement Advisory Services
Plymouth,
Minnesota
| USD 32 M | +USD 1.71 M | 26 | 0.05% | Aumentadas |
|
| 324 |
M&T Bank
Buffalo,
New York
| USD 32 M | +USD 1.78 M | 8 | 0.09% | Aumentadas |
|
| 325 |
Walleye Capital
New York
| USD 31.6 M | -USD 13 M | 18 | 0.11% | Reducidas |
|